![banner-cell-2](https://ocugen.com/wp-content/uploads/2024/01/banner-cell-2-1916x735.png)
![mobile-cell](https://ocugen.com/wp-content/uploads/2024/01/mobile-cell-374x371.png)
Cell Therapies
NeoCart®
NeoCart® is a three-dimensional tissue-engineered disc of new cartilage that is manufactured by growing chondrocytes – the cells responsible for maintaining cartilage health – derived from the patient on a unique scaffold. NeoCart® has the potential to accelerate healing and reduce pain by rebuilding a patient’s damaged knee cartilage. It treats pain at the source, creating a similar, functional joint surface as it was before the injury. Ultimately, the goal is to prevent a patient’s progression to osteoarthritis. NeoCart® was acquired as a part of Ocugen’s reverse merger with the original developer of the therapy, Histogenics, in 2019.